Search patents:
KINASE INHIBITOR
KINASE INHIBITOR
Filed: March 10th, 2009 [Pending]
Assignee: SANOFI-AVENTIS
Patent Application Number: 12401254
US 2010/0035884 Al (43) Pub. Date: Feb. 11, 2010 (54) KINASE INHIBITOR (75) Inventors: Timothy A. GILLESPY, Hillsborough, NJ (US); Paul EYNOTT, Bedminster, ...
Tyrosine kinase inhibitors
Tyrosine kinase inhibitors
Filed: January 21st, 2003 [Pending]
Patent Application Number: 10501891
Oncogenic v-Abl tyrosine kinase can inhibit or stimulate growh, depending on the ... Structural mechanism for STI-571 inhibition of abelson tyrosine kinase.
SPECIFIC KINASE INHIBITORS
SPECIFIC KINASE INHIBITORS
Filed: August 6th, 2009 [Pending]
Patent Application Number: 12536884
[0050] Such models allow, in view of the present invention, one not only to predict the structures of novel kinase inhibitors that can inhibit a protein ...
NANOPARTICULATE COMPOSITIONS OF MITOGEN-ACTIVATED PROTEIN (MAP) KINASE ...
NANOPARTICULATE COMPOSITIONS OF MITOGEN-ACTIVATED PROTEIN (MAP) KINASE ...
Filed: December 7th, 2005 [Pending]
Patent Application Number: 11275069
[0078] The bioadhesive MAP kinase inhibitor compositions of the invention ... [ 0079] A bioadhesive MAP kinase inhibitor composition slows the transit of the ...
Pharmaceutical agent containing Rho kinase inhibitor
Pharmaceutical agent containing Rho kinase inhibitor
Filed: July 31st, 2002 [Pending]
Patent Application Number: 10208100
[0581] In addition, since Rho kinase inhibitors of the present invention have strong Rho kinase inhibitory activity, they are also useful as reagents for ...
Kinase inhibitors for the treatment of diabetes and obesity
Kinase inhibitors for the treatment of diabetes and obesity
Filed: October 28th, 2005 [Pending]
Patent Application Number: 11260164
... Naik Takayanagi Bachovchin tyrosine kinase inhibitors, tyrosine kinase inhibitors. l-cycloproppyl-4-pyridyl-quinolones tyrosine kinase inhibitors.
Kinase inhibitors
Kinase inhibitors
Filed: October 27th, 2005 [Granted]
Patent Number: 7901894
The present method is designed to preferentially provide protein kinase inhibitors which do not act by inhibiting ATP binding to the protein kinase.
COMBINED TREATMENT WITH AN EGFR KINASE INHIBITOR AND AN AGENT THAT ...
COMBINED TREATMENT WITH AN EGFR KINASE INHIBITOR AND AN AGENT THAT ...
Filed: December 4th, 2009 [Pending]
Patent Application Number: 12631116
This work demonstrated that epithelial cells respond well to EGFR kinase inhibitors, but that after an EMT the cells become much less sensitive to such ...